X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALKEM LABORATORIES - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALKEM LABORATORIES PFIZER/
ALKEM LABORATORIES
 
P/E (TTM) x 35.2 - - View Chart
P/BV x 5.7 7.0 81.6% View Chart
Dividend Yield % 0.7 0.6 106.9%  

Financials

 PFIZER   ALKEM LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-17
ALKEM LABORATORIES
Mar-16
PFIZER/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,0551,589 129.3%   
Low Rs1,6511,232 134.0%   
Sales per share (Unadj.) Rs429.8417.5 103.0%  
Earnings per share (Unadj.) Rs73.656.3 130.8%  
Cash flow per share (Unadj.) Rs87.464.7 135.0%  
Dividends per share (Unadj.) Rs20.0012.70 157.5%  
Dividend yield (eoy) %1.10.9 119.9%  
Book value per share (Unadj.) Rs528.7292.9 180.5%  
Shares outstanding (eoy) m45.75119.57 38.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.33.4 127.6%   
Avg P/E ratio x25.225.1 100.5%  
P/CF ratio (eoy) x21.221.8 97.3%  
Price / Book Value ratio x3.54.8 72.8%  
Dividend payout %27.222.6 120.4%   
Avg Mkt Cap Rs m84,777168,653 50.3%   
No. of employees `0002.8NA-   
Total wages/salary Rs m3,0399,171 33.1%   
Avg. sales/employee Rs Th6,925.9NM-  
Avg. wages/employee Rs Th1,070.4NM-  
Avg. net profit/employee Rs Th1,186.3NM-  
INCOME DATA
Net Sales Rs m19,66349,915 39.4%  
Other income Rs m1,0121,645 61.5%   
Total revenues Rs m20,67451,561 40.1%   
Gross profit Rs m3,4918,482 41.2%  
Depreciation Rs m6291,006 62.6%   
Interest Rs m10671 1.4%   
Profit before tax Rs m3,8648,451 45.7%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1,3040-   
Tax Rs m1,8011,606 112.1%   
Profit after tax Rs m3,3686,731 50.0%  
Gross profit margin %17.817.0 104.5%  
Effective tax rate %46.619.0 245.2%   
Net profit margin %17.113.5 127.0%  
BALANCE SHEET DATA
Current assets Rs m20,78927,062 76.8%   
Current liabilities Rs m7,87015,324 51.4%   
Net working cap to sales %65.723.5 279.4%  
Current ratio x2.61.8 149.6%  
Inventory Days Days6067 89.9%  
Debtors Days Days2241 54.3%  
Net fixed assets Rs m9,17512,610 72.8%   
Share capital Rs m458239 191.3%   
"Free" reserves Rs m23,73134,490 68.8%   
Net worth Rs m24,18935,027 69.1%   
Long term debt Rs m251,212 2.1%   
Total assets Rs m32,70654,387 60.1%  
Interest coverage x403.513.6 2,966.4%   
Debt to equity ratio x00 3.0%  
Sales to assets ratio x0.60.9 65.5%   
Return on assets %10.313.6 75.9%  
Return on equity %13.919.2 72.4%  
Return on capital %21.424.9 86.0%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m636,563 1.0%   
Fx outflow Rs m4,0673,012 135.0%   
Net fx Rs m-4,0043,552 -112.7%   
CASH FLOW
From Operations Rs m3,2887,259 45.3%  
From Investments Rs m-2,4961,864 -133.9%  
From Financial Activity Rs m-826-9,273 8.9%  
Net Cashflow Rs m-35-150 23.1%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 33.1 22.7%  
FIIs % 4.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 0.0 -  
Shareholders   85,207 68,381 124.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Depreciating Rupee; IPO Buzz and Top Cues in Focus Today(Pre-Open)

Indian share markets ended lower yesterday with banking stocks and metal stocks leading the losses. At the closing bell, the BSE Sensex ended down by 188 points (0.5%).

Related Views on News

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY18); Net Profit Up 53.6% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, PFIZER has posted a net profit of Rs 1 bn (up 53.6% YoY). Sales on the other hand came in at Rs 5 bn (up 14.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 17, 2018 09:09 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS